An MSP team discovers a breach exposing oncology trial data from the Aurora 7 study, affecting 230 patients and a $47 million clinical trial. They must choose between shutting down systems, notifying the client, protecting the trial, or investigating further, with regulators and investors watching every move.
Aurora 7 was supposed to change the future of oncology research. Then one compromised inbox opened the door. Trial data, patient records, proprietary research methods, all moving out before anyone notices. Now your MSP team has to make the calls. Do you shut it down? Notify the client? Protect the trial? Or keep investigating while the attacker stays ahead? 230 patients may be affected. Regulators need answers. Investors are calling. And a $47 million trial is still on the line. Every decision changes the outcome. Every delay has a cost. Join Trouble in Techland: The Aurora 7 Breach. Can your team stay ahead?
